Purpose The phytosteroid ecdysterone was recently reported to enhance performance in sports and may thus be considered as a substance of relevance in anti-doping control. To trace back an administration of ecdysterone from urine samples, analytical properties have been investigated to assess its integration into initial testing procedures (ITP) in doping control laboratories. Methods Analytical properties of ecdysterone were evaluated using gas chromatography-quadrupole/time-of-flight-mass spectrometry (GC-QTOF-MS) and liquid chromatography (LC)-QTOF-MS. Its metabolism and elimination in human were studied using urines collected after administration. Results The detectability of ecdysterone by GC-MS (after derivatization) and/or LC-MS(/MS) has been demonstrated and sample preparation methods were evaluated. Dilute-and-inject for LC-MS(/MS) or solid phase extraction using Oasis HLB for GC-MS or LC-MS were found most suitable, while liquid-liquid extraction was hampered by the high polarity of ecdysteroids. Most abundantly, ecdysterone was detected in the post administration urines as parent compound besides the metabolite desoxy-ecdysterone. Additionally, desoxy-poststerone was tentatively assigned as minor metabolite, however, further investigations are needed. Conclusion An administration of ecdysterone can be targeted using existing procedures of anti-doping laboratories. Ecdysterone and desoxy-ecdysterone appeared as suitable candidates for integration in ITP. Using dilute-and-inject a detection of the parent compound was possible for more than 2 days after the administration of a single dose of ~ 50 mg.
Introduction
Ecdysterone (chemical structure in Fig. 1) is widely marketed as a "natural anabolic agent", advertised to increase strength and muscle mass during resistance training to reduce fatigue and to ease recovery. Growth promoting and anabolic effects in various animal species including humans have been reported [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] . Ecdysterone appeared to promote an anabolic effect that was reported to be even stronger than that of the anabolic androgenic steroid (AAS) metandienone [19, 20] . Contrary to the effect of AASs, it appears that the effect of ecdysterone is mediated by an activation of estrogen receptor beta (ERbeta) [1, [21] [22] [23] . A few studies reported a performance-enhancing effect in animals, but only recently, a controlled administration trial in humans showed significant performance enhancement in resistance training [24] . Thus, the administration of ecdysterone may be considered as a practice that leads to an unfair advantage in sports competitions and may, therefore, be considered as doping. Indeed, ecdysterone was already suspected to be used by Olympic athletes since the 1980s and was also called a "Russian secret" [11, 19, 20, [24] [25] [26] .
The administration of prohibited substances in sports is generally traced back from the analysis of biological specimen. The majority of substances is covered by the analysis of urine samples from athletes utilizing mass spectrometric detection hyphenated to chromatographic separation [27, 28] . Sample preparation often includes cleavage of potential phase-II metabolites, concentration of the analytes using liquid-liquid (LLE) or solid-phase extraction (SPE). For gas chromatography-mass spectrometry (GC-MS) analysis derivatization of the analytes to their trimethylsilyl (TMS)derivatives is most frequently performed for less volatile compounds [28] [29] [30] .
A few studies report the metabolism of ecdysterone, however, most of them do not refer to humans [3, [31] [32] [33] [34] . As stated by Lafont et al. [31] considerable differences between species have been observed and thus, transferability is questionable. In humans, desoxy-ecdysterone was reported as urinary metabolite; however, structure assignment differed between the two studies. While Brandt [34] reported 14-desoxy-ecdysterone, a 2-desoxy metabolite was described in Tsitsimpikou et al. [33] .
Herein, we investigate the analytical properties of ecdysterone and evaluate different alternatives to trace back its administration from the analysis of doping control samples using GC-or LC-MS-based methods. Analytical properties are provided to support the decision for the most suitable procedure for initial testing in doping control laboratories.
Materials and methods

Chemicals and reagents
Reference substances of the phytosteroids ecdysterone (2β,3β,14α,20β,22R,25-hexahydroxy-5β-cholest-7-en-6-one, parent compound, PC) and ecdysone (2β,3β,14α,22R,25-pentahydroxy-5β-cholest-7-en-6-one, 1) were purchased from Steraloids (Newport, RI, USA), while ponasterone (2β,3β,14α,20β,22R-pentahydroxy-5β-cholest-7-en-6-one, 2) was obtained from Cayman Chemical Company (Ann Arbor, Michigan, MI, USA). Methyltestosterone (used as internal standard for urine analysis) was obtained from Sigma-Aldrich (Milano, Italy).
The preparation of β-glucuronidase from Escherichia coli was from Roche Diagnostics (Mannheim, Germany), β-glucuronidase arylsulfatase mix from Sigma-Aldrich Chemie GmbH (Taufkirchen, Germany). The derivatizing agent (TMIS reagent) was a mixture of N-methyl-N-trimethylsilyltrifluoroacetamide (MSTFA)/ammonium iodide (NH 4 I)/dithioerythritol (DTE) (1000:2:4 v/w/w) stored in screwed cap vials at 4 °C for a maximum of 2 weeks. MSTFA was supplied by Chemische Fabrik Karl Bucher GmbH (Waldstetten, Germany), NH 4 I and DTE were supplied by Sigma-Aldrich (Milano, Italy). Solvents (t-butyl methyl ether, ethyl acetate, methanol) and reagents (potassium carbonate, sodium phosphate, sodium hydrogen phosphate, sodium hydrogen carbonate) were of analytical or HPLC grade and provided by Sigma-Aldrich (Milano, Italy) or VWR (Darmstadt, Germany). Water was obtained from a MilliQ water purification system (Millipore S.p.A., Milano, Italy) or a LaboStar 2-DI/UV system (SG Wasseraufbereitung und Regeneration GmbH, Barsbüttel, Germany) equipped with LC-Pak Polisher and a 0.22-μm membrane point-of-use cartridge (Millipak).
Synthesis of 14-desoxy-ecdysterone (3)
Desoxygenation of ecdysterone was performed as described by Kumpun et al. [3] . A solution of 200 mg of ecdysterone in 2.4 mL of acetic acid was treated with 250 mg of zinc powder, while stirring for 24 h at 70 °C. After filtration, an aliquot was diluted with water and analyzed by LC-QTOF-MS. Three desoxy-ecdysterone isomers were detected with the two major assigned according to Kumpun et al. and Zhu et al. [3, 35] to 14α-H (most abundant, earlier eluting, 3) and 14β-H product (second most abundant, later eluting, 3b). 
Urine samples
Post-administration urines were collected following the administration of 51.5 mg of ecdysterone (checked for identity and purity) to one healthy volunteer. All samples (as they accrued) were collected for 33 h, followed by spot urines of the following 3 days. Samples were stored in aliquots at − 18 °C and gently thawed at + 4 °C for sample preparation.
Instrumentation
Analyses were performed evaluating different instruments, i.e. GC-QTOF-MS, LC-QTOF-MS and LC-QQQ-MS as described below. Mass Hunter B10 software from Agilent Technologies Inc. (Santa Clara, CA, USA) and Analyst Version 1.6.2 (AB Sciex, Monza, Italy) software were used for data acquisition and processing.
LC-QTOF-MS
LC-high-resolution mass spectrometry (HRMS) was performed on an Agilent 6550 Q-TOF mass spectrometer coupled to an Agilent 1290 II ultra-high performance liquid chromatograph (UHPLC) equipped with an Agilent Eclipse Plus C18 column (2.1 mm × 100 mm, particle size 1.8 μm). A linear gradient (starting at 5% B and increasing to 25% at 7 min, then to 95% at 13 min, 3 min hold, followed by 2 min re-equilibration at 5% B) was used with water-containing formic acid (1000:1, v:v, eluent A) and acetonitrile and formic acid (1000:1, v:v, eluent B) as mobile phase constituents at a flow rate of 0.5 mL/min. Ionization was performed by electrospray ionization (ESI) in positive mode using a Jet Stream ESI source and Ion Funnel (Agilent Technologies GmbH, Waldbronn, Germany). In ESI +, a capillary voltage of 3,500 V, a nozzle voltage of 300 V, a drying gas flow of 15 L/min at 150 °C, sheath gas flow of 12 L/min at 375 °C and a nebulizer pressure of 25 psi were used. The high-pressure ion funnel was operated at radio frequency (RF) voltage 150 V, the low-pressure funnel at RF 60 V, and the octopole at RF 750 V. The analyses were performed in full-scan MS as well as targeted MS/MS mode or auto MS/MS mode at a mass range of m/z 50-1000. In MS/MS experiments, nitrogen was used as collision gas and collision energies were ramped with precursor mass (slope: 6; offset: 4). Mass resolution (full width at half maximum, FWHM) within the analyzed m/z range was 12,000-25,000 (based on the QTOF mass calibration data of 118.086255-1521.971475). Purine ([M + H] + = 121.0509 and the Agilent compound HP0921 ([M + H] + = 922.0098) were simultaneously introduced into the ion source and used for internal mass calibration throughout the analysis.
LC-QQQ-MS
The LC-MS/MS instrument comprised of an Agilent 1200 with binary gradient system (Agilent Technologies S.p.A, Cernusco sul Naviglio, Milano, Italy) coupled to an API 4000 triple quadrupole mass spectrometer (ABSciex, Monza, Italy). Ionization was performed by ESI in positive mode, using a curtain gas pressure of 25 psi, a source temperature of 550 °C, an ion source gas 1 pressure of 35 psi, an ion source gas 2 pressure of 40 psi, a declustering voltage of 80 V, an entrance potential of 10 V and a needle voltage of 5500 V. The experiments were performed using multiple reaction monitoring (MRM) as acquisition mode, employing collision-induced dissociation (CID) using nitrogen as collision gas at 5.8 mPa, obtained from a dedicated nitrogen generator system (Parker-Balston model 75-A74, gas purity 99.5%, CPS Analitica Milano, Italy). The ion transitions selected for ecdysterone were: 481 → 371 (CE = 28 eV), 481 → 445 (CE = 25 eV), and 481 → 165 (CE = 35 eV), whereas for ecdysone and ponasterone, the selected ion transitions were 465 → 447 (CE = 25 eV), 465 → 429 (CE = 27 eV) and 465 → 285 (CE = 27 eV).
The reversed phase (RP)-HPLC separation was adopted from the method currently used in the World Anti-Doping Agency (WADA) accredited anti-doping laboratory of Rome [36] using a Supelco discovery C18 column (2.1 × 150 mm, 5 μm, Sigma Aldrich, Milano, Italy) with a mobile phase of water-containing formic acid (1000:1, v:v, eluent A) and acetonitrile and formic acid (1000:1, v:v, eluent B). The gradient program starts at 10% of eluent B and increases to 60% of eluent B in 3 min, 6 min hold, then to 90% of eluent B in 2 min, 1 min hold, followed by 4 min re-equilibration at 10% of eluent B. The flow rate was set at 250 µL/min and the column was maintained at ambient temperature. Aliquots of 10 µL were injected using an Agilent 1200 autosampler.
GC-QTOF-MS
GC-QTOF-MS was performed as regularly done in the Anti-Doping Laboratory in Rome. An Agilent 7200 GC-QTOF-MS (Waldbronn, Germany) coupled by electron ionization (EI, 70 eV at 250 °C) to an Agilent 7890B GC was equipped with an HP Ultra1 capillary column (length 17 m, 0.2 mm i.d., 0.11 µm film thickness, Agilent Technologies, Waldbronn, Germany). Helium was used as carrier gas (1 mL/ min, constant flow) and the oven temperature was programmed at 188 °C (2.5 min hold), increased at 3 °C/min to 211 °C (2 min hold), at 10 °C/min to 238 °C, at 40 °C/min to 320 °C (hold 3.2 min). An aliquot of 2 µL was injected in split mode (1:20) . Improved separation used a modified temperature program, however, evaluation was intended to use the routinely performed separation of the laboratory to meet initial testing procedures.
Reference solutions or the final extracts of sample preparation were evaporated and derivatized using 100 µL of TMIS reagent.
Evaluation of pre-analytical sample processing
Extraction procedures
To evaluate the possibilities of extraction and concentration of the analytes, ecdysterone parent compound was used as model substance. For SPE, different cartridges (HLB Oasis HLB and WCX, both Waters, Milan, Italy, as well as Chromabond C18, C18 Hydra, and HR-X, all Macherey-Nagel, Düren Germany) were tested. After conditioning, cartridges were loaded with 2 mL of urine spiked with ecdysterone. After washing, elution was performed with 1 mL of methanol (either with or without addition of formic acid or ammonium formate). The eluate was evaporated and reconstituted in 50 µL of purified water to yield the injection solution for LC-MS analysis.
Additionally, LLE was evaluated at different pH values and using different extraction solvents. Aliquots of 2 mL of blank urine spiked with ecdysterone were adjusted to pH 5, 7 or 9 and extracted with 5 mL of solvent (TBME, ethyl acetate, chloroform, or a mixture of chloroform with isopropanol). Analyses were performed by LC-MS/MS.
Recoveries were determined by comparison with a reference solution spiked into urine after the extraction.
Application to post administration samples
For LC-MS analysis, urine samples were spiked with the internal standard methyltestosterone, diluted with water (1:4, v:v) and injected into the system after centrifugation at 800 g.
Alternatively, GC-QTOF analysis was performed after extraction and derivatization using a mixture of MSTFA:NH 4 I:DTE (1000:2:4, v/w/w, TMIS reagent) within 2 h at 75 °C.
For evaluation of a potential cleavage of phase-II metabolites enzymatic hydrolysis with β-glucuronidase or a mixture of β-glucuronidase and arylsulfatase was performed before the analysis.
To 2 mL of each urine sample adjusted to pH 7 by addition of 1.5 mL of phosphate buffer, 50 µL of internal standard solution (methyltestosterone, 200 ng/mL) and 50 µL of β-glucuronidase were added. Deglucuronidation was performed within 1 h at 50 °C.
Additionally, cleavage of potential glucuronides and sulfates was performed while incubating 2 mL of urine, adjusted to pH 5.2, with 50 µL of β-glucuronidase arylsulfatase mix after addition of the internal standard (methyltestosterone). Incubation was carried out for 3 h at 50 °C.
Results
Mass spectrometry
The mass spectrometric properties of ecdysterone and the two other ecdysteroids ecdysone and ponasterone (both desoxy analogues of ecdysterone accessible as reference materials) as well as the synthesized 14-desoxy-ecdysterone were analyzed by GC-MS and LC-MS. Derivatization, that was required for GC-MS analyses, was performed using TMIS reagent that is most frequently utilized in anti-doping laboratories. Ecdysterone mainly yielded a per-TMS derivative (ecdysterone 5-en-6-ol heptakis-TMS derivative) eluting at 18.69 min. The most abundant fragments were detected at m/z 633.3673 (C 33 [33] . The EI spectrum is displayed in Fig. 2 . Additionally, Fig. 2 125.0961, mass error ∆m/z = 0.8 ppm). Furthermore, the ion at m/z 191.1068 may be assigned to C1-C11 + C19 after loss of water (C 12 H 15 O 2 + , exact mass 191.1067, mass error ∆m/z = 0.5 ppm). Similar fragments were reported by Brandt [34] , however, in unit mass resolution.
Following derivatization 14-desoxy-ecdysterone (3) yielded a per-TMS derivative as well (14-desoxy-ecdysterone 5-en-6-ol hexakis-TMS derivative) eluting slightly earlier than ecdysterone-per-TMS (RT M3 = 18.65 min). The most abundant fragments were detected at m/z 635.3822 (C 33 
Extraction procedure
Extraction was evaluated using TBME that is utilized in lots of extraction procedures in anti-doping laboratories and recoveries were compared with less common solvents such as ethyl acetate, chloroform, or a mixture of chloroform with isopropanol. Almost independent of the pH of the aqueous phase extraction yields in LLE were generally low (<23%) with TBME giving the lowest recovery (<5%) of all extraction solvents tested in this investigation. SPE using Oasis HLB resulted in the highest recovery (96%) for extraction after optimization of the procedure. According to the literature, Lichrolut RP-18 also gave acceptable recoveries of 72-96% [34] . 
Detection of ecdysterone metabolites in urine
Considering the above-mentioned pre-analytical properties, it was decided to investigate the urinary elimination of ecdysterone using dilute-and-inject. The majority of experiments was performed using LC-QTOF-MS in MS1 mode, with MS/MS experiments utilized for confirmation. In the post-administration urines, the parent compound ecdysterone was found as most abundant analyte. No differences in abundance were found after enzymatic hydrolysis either with β-glucuronidase or β-glucuronidase/arylsulfatase. Additionally, neither ecdysterone glucuronide nor ecdysterone sulfate were detected in the non-hydrolyzed samples. Furthermore, the presence of a desoxy metabolite was confirmed in the post administration urines. were excluded by comparison with the authentical references of ecdysone and ponasterone. Utilizing MS/MS (spectrum in Fig. 6 upper) , the comparison with the product ion spectrum of 14-desoxy-ecdysterone as reported in Fig. 5 revealed high similarities, thus considering high probability of conformance. Additionally, the GC-QTOF-MS analysis showed a signal matching 14-desoxy-ecdysterone spectrum and retention time. As already discovered for ecdysterone, no relevant phase-II metabolite was detectable by accurate mass in the non-hydrolyzed samples and no increase in abundance was detected after enzymatic hydrolysis.
Additionally 
Excretion profiles
Following a single oral dose of 51.5 mg of ecdysterone, the parent compound was detectable by LC-QTOF-MS for more than 2 days using dilute-and-inject. The maximum concentration was observed in the 2.0-3.5 h urine. The desoxy metabolite M3 shows a smaller detection window compared to the parent compound. The maximum concentration was detected in the 7.25-9.0 h urine, and latest detection was achieved in the 25.2-29 h urine. The excretion profiles of both metabolites are displayed in Fig. 7 . A biphasic excretion of the two desoxy-poststerone isomers has been also observed, however, needs further investigation.
Discussion
GC-MS after per-trimethylsilylation as well as LC-QTOFand QQQ-MS were all found suitable for the detection of ecdysterone and its metabolites. SPE using Oasis HLB resulted in the highest recovery (96%) for extraction after optimization of the procedure. According to the literature, utilization of Lichrolut RP-18 cartridges also gave recoveries of 72-96% [34] . Ecdysterone is known as a relatively polar steroid (logP = − 0.53, according to ACDLabs prediction and reported at www.scifi nder.cas. org). Ecdysone and ponasterone show slightly less polarity (logP ecdysone = 0.875, logP ponasterone = 1.434), however, still even more polar compared to cortisol (logP cortisol = 1.762, for comparison logP testosterone = 3.179). This explains the low recoveries in LLE in comparison to SPE. Thus, it is suggested to perform either dilute-and-inject or SPE for sample preparation rather than LLE.
In post-administration urine samples, the presence of ecdysterone was confirmed by comparison with authentical reference material. Furthermore, the presence of a desoxy metabolite (M3) in the post-administration urines was assigned to 14-desoxy-ecdysterone by comparison of retention time and MS data with the synthesized reference material. In GC-MS analyses, fragments looked very similar to those reported for 2-desoxy-ecdysterone by Tsitsimpikou et al. [33] , however, showing different relative abundances. As already commented by Lafont and Dinan [10] , mass spectrometry alone is not capable of providing data suitable for unambiguous assignment of the exact isomer in some cases. Even worse, also product ion spectra of ecdysteroids after ESI are dominated by losses of water that are not suitable for a discrimination of the position of desoxygenation at the sterane moiety. Similarly, the EIspectra reported by Tsitsimpikou et al. [33] are dominated by cleavage of the sterane moiety from the side chain and Only the dihydro-ecdysone isomer 5β-cholest-8(14)-ene-2β,3β,6α,22R,25-pentol) was reported to be substantiated by nuclear magnetic resonance and ultra-violet spectroscopy as well. None of these compounds was detected in our study. As the study of Kumpun et al. was performed in mice with the analysis accomplished based on urine and feces with no clear indication which metabolite was excreted in which specimen, the transfer to our study may be not fully applicable. Pathways of metabolite generation should be evaluated in the future to better understand potentially influencing factors. If desoxygenation is indeed caused by gut bacteria as postulated by Kumpun et al. [3] , the bacterial composition may highly influence metabolite excretion. An evaluation of post-administration urines of different volunteers is thus highly desired.
No relevant phase-II metabolites of ecdysterone or one of its metabolites were detectable by accurate mass in the non-hydrolyzed samples and no increase in abundance was detected after enzymatic hydrolysis. This is in line with the findings in mice reported by Lafont et al. [31] .
Furthermore, ecdysterone is often administered from plant extracts, such as spinach or suma root. Thus, additional phytosteroids (e.g. ecdysone, ponasterone, and others) may be ingested aside in those cases. These steroids as well as their metabolites may be found in excretion urines as well.
Conclusion
Ecdysterone and its desoxy metabolite may be easily integrated in current initial testing procedures for monitoring the prevalence in elite sports. The administration of ecdysterone results in an excretion of the parent compound in the urine. Targeting the parent compound is ideally performed by LC-HRMS or LC-MS/MS by dilute-and-inject. Alternatively, GC-MS analysis is possible after TMS derivatization. If extraction is required or desired, SPE was found to be by far superior to LLE. Enzymatic hydrolysis did not provide Fig. 8 Chemical structures of desoxy-ecdysterone, poststerone and desoxy-poststerone proposed as metabolites of ecdysterone in the literature [3, 33, 34] advantages over the analysis of the unconjugated fraction only.
Due to the potential generation of metabolites by gut bacteria that may cause significant variations in the metabolic profile, an integration of further isomers and analogues may also be appropriate.
